Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

M. Cavo, E. Terpos, C. Nanni, P. Moreau, S. Lentzsch, S. Zweegman, J. Hillengass, M. Engelhardt, S.Z. Usmani, D.H. Vesole, J. San-Miguel, S.K. Kumar, P.G. Richardson, J.R. Mikhael, F.L. da Costa, M.-A. Dimopoulos, C. Zingaretti, N. Abildgaard, H. Goldschmidt, R.Z. OrlowskiW.J. Chng, H. Einsele, S. Lonial, B. Barlogie, K.C. Anderson, S.V. Rajkumar, B.G.M. Durie, E. Zamagni

Research output: Contribution to journalArticle

Cite this

Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., San-Miguel, J., Kumar, S. K., Richardson, P. G., Mikhael, J. R., da Costa, F. L., Dimopoulos, M-A., Zingaretti, C., Abildgaard, N., Goldschmidt, H., ... Zamagni, E. (2017). Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. The Lancet Oncology, 18(4), e206-e217. https://doi.org/10.1016/S1470-2045(17)30189-4